Espacenet - Bibliographic data
`
`Page 1 of 2
`
`
`
`Espaeenet
`
`Bibiiogragshio state: JP20??51885? {A} m 20t?»0?~’t3
`
`NGNJNVASNE NERVE STEMQLATEGN Vii-3t MGBELE DEVESES
`
`Inventor(s):
`
`I'J—ZI o‘er—t7 6—, ; xp-‘fx x-fl—o‘v, ; #44?) jib—x
`9‘14
`
`Applicant(s):
`
`II/JHZI2I7 use/r 547:“ U714 jam;—
`
`Classification:
`
`-international: Afithit/Efi
`- cooperative:
`A31N’ii0455; AS’EN’EIZfififiZ’i; AE’EN’iiSEtEZES
`
`Application
`number:
`
`JP20170513603 20150520
`
`Global Dossier
`
`Priority number U3201462001004P 20140520 ; LES-2201414292401 20140530 ;
`(s):
`US201414335726 20140718 ; U3201414335?84 20140?18 ;
`W02015U83’l 847 20150520
`
`Also published CN106794348 gAi EP3145585 gm 2 EP3145585 {A4}
`as.
`'
`KR20170027722 A ‘N0201517957‘i A‘E
`
`Ahstrast not avaiiahie for JPEQ‘E‘E’S‘E 835? he}
`Abstract of oorresoonding tiesoment: 33530201 St "refit {At}
`
`Devices, systems, and methods are disoiosed that aliow a patient to seif~treet a
`medioai oondition, such as a migraine headachean epileptic seizure, a
`neurodegenerative disease; such as dementia, Aizheimer’s disease, isohemio stroke,
`postuoonoussion syndrome, ohronio traumatic encephalopathy or the iiite, by eieotriosi
`non—invasive stimniation of a vagus nerve. The system can oomprise a handheid
`stimtiiator whioh is sooiied to a surface of the patients neoitl wherein the stimulator
`comprises or is joined to a mobile device, A camera of the mobiie device may he used
`to position and reposition the stimniator to a nertiouiar iooation on the patients neck.
`The system may also comprise a base station that is used to meter the charging of a
`rechargeahie battery within the stimuiator. The base station and stimtiiater transmit
`data to one another regarding the status of a stimulation session.
`
`https://wor1dwide.espacenet.com/publicationDetails/biblio?II=1&ND=3&adjacent=true&loc. .. 8/6/2019
`
`
`
`Page 1 of 2
`
`
`
`Espaeenet
`
`Bibiiogragshio state: JP20??51885? {A} m 20t?»0?~’t3
`
`NGNJNVASNE NERVE STEMQLATEGN Vii-3t MGBELE DEVESES
`
`Inventor(s):
`
`I'J—ZI o‘er—t7 6—, ; xp-‘fx x-fl—o‘v, ; #44?) jib—x
`9‘14
`
`Applicant(s):
`
`II/JHZI2I7 use/r 547:“ U714 jam;—
`
`Classification:
`
`-international: Afithit/Efi
`- cooperative:
`A31N’ii0455; AS’EN’EIZfififiZ’i; AE’EN’iiSEtEZES
`
`Application
`number:
`
`JP20170513603 20150520
`
`Global Dossier
`
`Priority number U3201462001004P 20140520 ; LES-2201414292401 20140530 ;
`(s):
`US201414335726 20140718 ; U3201414335?84 20140?18 ;
`W02015U83’l 847 20150520
`
`Also published CN106794348 gAi EP3145585 gm 2 EP3145585 {A4}
`as.
`'
`KR20170027722 A ‘N0201517957‘i A‘E
`
`Ahstrast not avaiiahie for JPEQ‘E‘E’S‘E 835? he}
`Abstract of oorresoonding tiesoment: 33530201 St "refit {At}
`
`Devices, systems, and methods are disoiosed that aliow a patient to seif~treet a
`medioai oondition, such as a migraine headachean epileptic seizure, a
`neurodegenerative disease; such as dementia, Aizheimer’s disease, isohemio stroke,
`postuoonoussion syndrome, ohronio traumatic encephalopathy or the iiite, by eieotriosi
`non—invasive stimniation of a vagus nerve. The system can oomprise a handheid
`stimtiiator whioh is sooiied to a surface of the patients neoitl wherein the stimulator
`comprises or is joined to a mobile device, A camera of the mobiie device may he used
`to position and reposition the stimniator to a nertiouiar iooation on the patients neck.
`The system may also comprise a base station that is used to meter the charging of a
`rechargeahie battery within the stimuiator. The base station and stimtiiater transmit
`data to one another regarding the status of a stimulation session.
`
`https://wor1dwide.espacenet.com/publicationDetails/biblio?II=1&ND=3&adjacent=true&loc. .. 8/6/2019
`
`
`
`Espacenet - Bibliographic data
`
`Page 2 of 2
`
`
` ,A,
`.22, ##4##”
`z”.w'1"72
`
`
` in“; mg»,x...“
`
`
`
` :“p~m\\;“5
`
`
`r”.
`
`
`
`1!!r”71’!!!
`
`
`n",
`
`
`
`S;
`
`\\\\\\\\\\\\\\\\
`
`\
`
`
`
`
`
`.
`i
`.
`\
`2‘“ .
`“?“““““‘“““
`
`
`\v‘\\\\\\\\mm\\\\\\\\\\\~\\\"
`
`https://wor1dwide.espacenet.com/publicationDetails/biblio?II—1&ND—3&adjacent—true&loc. .. 8/6/2019
`
`
`
`JP 2017- 518857 A 2017.7.13
`
`(190325-44215013)
`
`(12) ’1} ii fi 3-? ’1}. $0)
`
`(11) 14941113414422
`lIfifiZOW-SBBST
`(mow-51$”)
`(43) 1.4% El 1111;291:1535 (2011.7. 13)
`
`6DMLU.
`A61N 1/36
`
`F1
`
`(313.01)
`
`A61N
`
`1/36
`
`i—Va—F(%%)
`4C053
`
`
`2397121: 5091131: 72:39:21: 51291151:
`(a as a)
`
`fifii2017—513803 (P2017—513803)
`(21) HEE§
`312m27$51220E1 (2015.5. 20)
`(86) (22) WEE)
`3Fh£29£FlE2SEI (2017. 1. 23)
`(85) flfiflmfitfl El
`PCT/US2015/031847
`@6)5322215E29%%
`702015/179571
`@7)EflE§£kBfifi§¥%
`mmmfinfiwaamanzm
`anafifififi
`(31)1§?E1§I$§% 62/001, 004
`(32) {£5135
`5131-3265155}? 20El (2014.5. 20)
`(33) fifi'flfiifil
`916- (US)
`(31) fififiifififi
`14/292, 491
`(32) @5513
`5Pfl265135fl 30El (2014.5.30)
`(33) fifififiiifil
`216- (US)
`(31) fififiifififi
`14/335, 726
`(32) @513 El
`3Ffi265fi7fi 18El (2014. 7. 18)
`(33) {EEIEIE-
`91%. (US)
`fififiufi<
`
`(71) HEA 516349367
`1V§b037 Uiva 547EU
`‘7‘4
`16:471.:—
`:1—v+—v—m O
`7fi9fififlfl
`7920 NZ$V§ 9y? TVV
`13—1“ 150 Z’f—I‘ 20]
`(74) REA 100035771
`#31: fig $3
`(74) REA 100088694
`#fii Efi¥3~1 E
`(74) REA 100094509
`#21:
`EHEFI
`100067013
`#121: 76% 3013
`
`C74)ftfl£)\
`
`“FF—E15
`
`60[fifiQZW]mfiffi4zéfiTé#&EWWfiMfi
`
`finlgfil
`§%W.HEE‘TA#A%W.RU.%HE.TW
`
`9n4v—fi.fim&flfi§.%%fififififi.fififl
`
`gfiflfi¥mmfifififi¥wfifié.fiiwfiwgfim
`
`#Egflmuiu.Eafifi&fl%tié?fi4z.9
`
`X?Afiflfififififiénéazmvz;bm.fifim
`
`Emifiufifién3$fiflflflfiéfii.ammflfi
`M.fi$¥fl4zéfiiitmchufififin%afi%
`
`¥N4zwflx5#.E%®§®fiflmfififlfibtfl
`
`flfiémfiflmitufifififimiékmmfimfih3
`
`a:w927Am.Em.flflfimwfifiafifimmv
`
`5Uwfigéfiw23kwcmu6h5N—zzf—9
`
`ayifii5o&—XX?—yay&UWflfim.NH
`
`twvaywfifiufiLTEuE?—9EEE?%O
`[Emm1m1A
`
`
`
`
`m1—rflm‘ E3
`
`9.... .--. g
`.,
`
`l——_jfl1ul
`- i.
`
`Illa-$14..“
`=5
`fl“
`.4 11-
`' 111..
`H
`
`
`
`
`
`(2)
`
`JP 2017- 518857 A 2017. 7. 13
`
`LfifififimfiE]
`
`[fififi1]
`fifimflfiflfigfitfififl?éEfi'fifiéfifi'én'jfiyfifiéfifii‘ fifiEEM'fifi‘JO’Wi‘
`
`fl
`
`fiffifiE§¢1%$5t:*§fi‘2$hk¥%%?lf{RICHXHU“:nfl‘DEfiE‘JltfififinévfiUifl
`fit‘
`
`fififiafihfikafitfifiéafifi?zwzaREE—5n. Efififlfififlifitififiwfifigflflffiflfllfifitfiz
`
`fiLT. fifimfiflflfififimfifiéififififi'ééT:mt:+fit:%fifiéffifié?5wt:+fit¢%%é
`
`$fl¢éifitgflfihél$w¥fitéflfi?é‘%%®fifi%%fi?étm®92?
`A:
`
`[fifiEZJ
`ma%%¥n42m\fi%%%r&u\mammfim.mafi%%%w—Wfiuraa
`
`\fiifi1ufifiwvzon
`
`[fififisl
`
`fifi%%?fl4zu\%%%%?&U\maflflfiu\mafi%%fiwfifinmfiwé
`
`\Eifi1~2®mfhblfiflfifiw915Ao
`
`IE$E41
`
`fifififi¥n4zm\%%%%T%U.m$W%fim.mflfifififiwyn<tE—fi
`
`EEfl?é#—ZEE?§\%$E1~3ufhfi1fifiafi®92?ho
`
`[fiiESJ
`
`fi?%%?fi41fi‘$9hU—fiLT?—9&§Efififififififlfifififi$vb7
`—§EE?N%ZT%§.fiifi1~4wmfhfl1fimafiwvtho
`fifi
`
`fiEEflEM~1oitfl§fl®§fléfi?é.fiifi1~5mufhb1fifififi®
`2%50
`
`[fififi7]
`$519Ekfi§fi®§fiflfifiih%fi%§z$V—9Eififii‘WEE%§I$
`
`v—9m\fifiwEWflEQWfiéflfiiétmn+fiEEfi4Vfiwzéimiéxfi
`
`Efififihé‘fififi6flfifimyl?ha
`
`[fififisl
`
`WEE%¥1$p—am‘mamfifiwnoyydmufifiéh%‘fi$fi7ufifiw
`91?Ao
`
`[fififi9]
`
`WEE%§I$p—9m\maflmfimnwvydmfimmmfifina‘fififi7u
`
`UIIIIL'IJ
`
`fiwvzon
`
`[Efifi101
`fifififi¥fl4zm\ma%%91$p—9E\maéfi4vfiwzéfiafifimfifi
`
`$6$5Kfi%?6—E®$%Efim?%\fififi7~9®wfnfl1finaflwvz;
`
`[fififi11]
`
`fiE—fi®fi%m\fifififi?fi4ZfififififivyD—Féhéfifi?ju7—95
`T&é‘%~fi1oufifimvszo
`
`fiifi12}
`
`fifl%%TTU&—Dayfi‘1—?417D75AEE?%~%fifi11flflfi®y
`
`:T-Ao
`
`fififi13}
`
`fiN
`
`EK‘fiEE%§I$b—9RU1Sitmfifimfiflnfififihéfififififii‘fl
`
`fifififim\mfifi%v:$p—aw51catnfifiwfifiufi%éfifiié$icfi
`
`fiéhé‘fiifi?~12®ufhfi1fitfifl®91?ho
`
`[fififl14}
`
`am
`fiafifififi\fiaflmfimno§>VWEmfifina"fifi1snafimvzfA
`
`10
`
`20
`
`30
`
`4O
`
`50
`
`
`
`
`
`(4)
`
`JP 2017-518857 A 2017.7.13
`
`fifififlfififidfi‘
`
`fifié‘ilfilfifi‘ {EME‘ 504B? Rifli‘fiifiE‘ Wfififififin 'Cfuii‘r‘o‘
`
`EU
`
`SHEODEFEE\ EEEE. 9H§1§flfi%§\
`
`fifiE’EEHfiBfi%\ E'Efi\
`
`fifi’éfififi. BEU‘ Tfiififi
`
`fifiééé‘fla’llx—jbl‘ofififinéfifilfi’éfiiéx §§3RIE1~2 7 (Db‘fhfl'l IEKEEifi
`@92?Aa
`
`[fififi291
`
`fiEEmEH\fi%®§®%fitfifli6$5tfim$né\fiifil~28®mfh
`
`m1fimfiflmvz?bo
`
`I¥$E3o}
`
`fifigfim‘fiimfiifififiwfifiEWEi%kmu+fi?%%‘fififi1~29m
`
`Ufnw1fitafimvtho
`[fififis11
`
`1O
`
`fififiwfifiéfifiiétmu+fiflfifi€%&$mb\
`
`fifimfiimflfim‘éfiflflfifimfiflfiéfiméfi‘ma$fiflflflfifi $¥A
`
`41%Eb\
`
`mfifiéfimbtfi%waiwfifiu1oitufiflwafi4yfiwzémm3fi‘m
`
`€31Difciififimfifi/rVNJI/R’EE'aEOJEPEEfiL'C.
`
`5%0371'35-7 Wwfifififltfim
`
`Wfiififiiztéat.fi%wfifi®%fifiio
`
`[fififi32}
`
`”)JQ:< t5fiflfifl§tc¥§§$§§fiikm57vy hEEaiLB’r—X
`fififiafifi?fl42ti\
`EE?5‘%$E31EEflmfiio
`
`20
`
`[fiifi33}
`
`fi%%%?N4ZH\FVU»E€?%~%$ESIEEfl®H%O
`
`[$ifi34}
`
`m%%%¥m4zm\%%%%éfité‘fififi31EEE®EEG
`
`[fififi35}
`fia¥fi¥flflfim\fi%%%mfifivfifién%\fififi31~33wufnw1fi
`
`uafiwfiio
`
`[fififiss}
`
`
`
`fiEififlflflfim\fi%%finmfiwena\‘mfis1~33®ufn#1ficaarm
`
`flmfiio
`
`[fiifi37]
`
`mfififi?fi4zn%%77U#—9ayéivyu—Hfiéztéitafiié‘%
`
`$E31~36®mfhb1fitfifl®fimo
`
`[%$E38}
`
`EE%%77U#—Davfi‘j—?41774»f$6‘fififi37fififi®fifio
`[fiifi39}
`
`fiEEfiE%EEE?6CtEEEE§?é~fififi31~38®vfhfl1fiflfifl
`
`mfiiu
`
`[fiXE4OI
`
`mEEEH\fifiififlmflfimu%é.fi$fi31~3gmmfnb1finfifi®fi
`$9
`
`[fififi41}
`
`HEEEM‘Efifié$fiflflflfitafimufi%téztéaété~fififi31~
`
`40®ufhfi1fifi$fi®fiio
`
`[fififi42}
`
`mafiflm\13itfi§fi®$fi§fifiwfinfiflfit\fiE19itmfifiwEE
`
`m‘fifl#fiflflmfiwfifibafivfi‘fiifi31~41wufhm1mfifiu
`
`[fiifi43]
`
`4y
`mfi1vakmfiflwfifi N»zm‘wawH—zbéfib‘fiafi—zbw%
`
`h%nm‘fifiw1N—xhbefiwfi1oom—thfififiéfib‘fiaflwzw%
`
`30
`
`4O
`
`50
`
`
`
`h%nm‘$1KHz~fizoKHz®Efifléfiié\fififi31~42®ufflfi1
`
`(5)
`
`JP 2017- 518857 A 2017. 7. 13
`
`Eufifiwfiio
`
`[$fifi44}
`
`mfigfl?%kw®%%®afiwfimbkmfiEfifib.mfififim,fifififiwwx
`
`fifi%fi?§:t&§t§§?é\fififi31~43®ufhfi1fifififl®fifia
`
`[fiifi45}
`
`$fiflfl$fimkwu‘¥—9&%%¥N42E%fifi%?é:t&fina§¢é\
`
`am
`
`$E31~44mmfhfi1fimafimfiio
`
`[fimfi46}
`an
`fiEfififiiE?6¥—9m.%%?7U#—vayfififi?fi41n§¢vn—Hfi
`%Zt&fl§?%\%$fi45EEfi®EEo
`
`1O
`
`[fiifi47}
`
`fififlfifi‘éfiffifi'Za-FI—fim‘ $fiflfifli§i§§®i¢§fléfiffifitf§tfiblz‘ fi$¥l<4 X
`
`l:fi?éi¢fiéi§€?6ltéfl§?6\
`
`EESRIE4 5 ~4 6 COUTTHbW IEICEBEECDYEE
`
`IE$E48}
`
`mfififi?EE¢6?—&m\mflififlmflfin\flfififiéfifiiéctéafib
`‘fiaEfififlm\fia$fiflflmfifi$mié$5E%®fifififiéfi?a‘fififi4
`
`5~47wmfhfi1fitfifi®fifiu
`[fiifi491
`
`fiEEafifim.Eu.¥fiflflflfifi%%mfimbtham1jitmfifi®%fi®
`
`@fiéflfibxfifi77U7—Dayfi‘EE‘%HE%EtfifK§%KEfiLTEE
`m1oitm§fimfifiwfiflémm?é‘Efifi48tfifi®fi%o
`[%m®fimmflfil
`
`[fifififi]
`
`[0001]
`
`fifimfiwfifiéfl
`
`xmm‘201455E203$fimfiafi$E%62/001,004%.2014
`
`$5fisoaflfiw*afififlfifil4/292,491%‘2014$7H1SE$R
`
`mfifi¥fimfifi14/335,726%\2014¢7H1samfiwfiafififlfifi
`
`14/335.784%®E%fi&$$?6£®TEU\fh?h%§fi?éitfi$9
`‘itmfimtfib‘%®$¢fi$fltflfiéhéo
`
`[fifififil
`
`[0002]
`
`20
`
`30
`
`$fifi®fifim\%fiamwtmm§fififiaml$wfi4yfiwx(fiU/itufi
`
`)mimu%fao$fifim‘fim\Hfifi‘rhwhikm%®mwfifiéfifi?%¥
`
`N41Rfifi$flfib\ilfim.fififi.C0?”42&Ufi%%‘Efi§fl$®EE
`ME§%ELT.EEEfitLTfi%?%OZh5®fi%&%fi?%kmmfifiéh&l
`
`$w¥4ymwx(&U/$km%)m.fififiv/Ehmamlz»¥éafib‘§%
`c\%tfifiwfiiWfifl‘#E§mmfiméhao
`
`4O
`
`[0003]
`
`fifiwfifiuafimm%%u5ztmfimfi%aofifitfifitwfiwfififlfiéhr
`mfiafiifififlfiflwfifimmbt%fim\flfi&—Xx—fl?%6uflfi&—Xx—
`
`hwflfim‘1soofifiuméfi\1950$$?m‘%fl?#9%fiégwfihafi
`
`tfi~Em®$flmfifl—xx—bmfi%3nrumwatoEm®$fimfifimr~E
`
`mfifiafi—Rx—tm1957$ufi%b.1960fiufimmfiéuflflflfimfl—
`
`11—3: fl{fi§%i‘hfco
`
`[0004]
`
`10:5.fifiéfibrflfingfiu—Féfififl%mctfififién.:nm.mfl
`
`Efimrbflmfimu—FEWUHH6C&®%§EE@<Lto1975im‘abm
`
`50
`
`
`
`1O
`
`20
`
`30
`
`4O
`
`50
`
`(6)
`
`JP 2017- 518857 A 2017. 7. 13
`
`'J svaammalt fi—XX—fiawfitflsfifi'b‘flflfifil‘ol OEaEEEiéi'ELCEU
`
`kofimwd—zx—hm.pfimwfiamgaavfiiuydfiKEflEiéctfifi
`$T%U\%flflfitbftfifl?éztfifi%f%é(DENOBKfi?§%Efi¥%
`
`6,738,667%E#fi.:wgfimfiewéamuwa.éfltéztuau.
`Elzflflfilll§lcafii<héJ ..
`'J —l:75~°sawcismaenarzm. &—1X—flli. 1:21:55;
`
`afifiafifi¥fi4zwmpaao
`
`[0005]
`
`mmzwaitlfillah flwflbflfifilcaéflfimfififlfl( HMfifiBEfiilifliflifi)
`
`‘63)”)
`
`.ans.xaafifiavm—eyvyfiswaaaveaeseaefiwafiaea
`
`tafccblcfiaméztfisfiabl‘oh-cué(Joel
`
`s. PERLMUTTERELU’JO
`
`nathan W.Mink.Deep brain stimulation.Ann
`
`u.Rev.Neurosci 29(2006):229-257)a
`
`[0006]
`
`COWfiwfififiUflwlflawlfiifili\ fil’Em‘FfiElCBliélfllfi'lfiififimflfiilcaé‘Fflim
`
`F_WH|TE, Shitong LififiJen
`Mflfiwfififiaa(Paul
`W.Chiu.Electroanalgesia:lts Role
`in Acut
`e
`and Chronic Pain Management.Anesth Ana
`
`lg 92(2001):505-513.usfi§¢6871099,E%rFulIy
`implantable microstimulator
`for
`spinal
`
`cord stimulation as
`
`a
`
`therapy for chroni
`
`c painJWHITEHURST,et
`
`all:J:%;)o
`
`[0007]
`
`fiififififlffii( fiififiéfiflfiitbfVNStifll‘pn‘Cué) ii. Efififlfiflwfiélfi‘fifié
`
`D Zflli.
`
`fii‘JJlC\ fifififi'flfifi'fifhfi‘hwififiwkmlififi%$1’1” %03l§\
`
`fiifiil-‘SJZU‘
`
`fiwflfigmififimfcbllfififiéhko 113$“. ZEiiiEi‘EPfili. Hafiiflllflififiltibeilzgéii
`éifit’bflé’}. «203%. $fifi€$fififlflfilcfifi1§lth$LJt
`E®¢QMET§U1§I$h
`
`6°(fii—‘Ffiu‘sus4702254ficfigNeurocybernetic prosth
`
`gal nerve s
`sis,ZABARAlCJ:%>;USS341236 IE'FE‘EVa
`or
`treatment
`0
`imulation techniques
`
`_-h
`
`l::il§;U85
`al
`O et
`opsychiatric di
`
`(DEG
`
`_0H1
`
`-o
`
`-n>1mx-
`
`1cmcomcm
`
`z e v
`
`E r
`
`ures,OS
`nt
`of
`n
`e sti
`
`s a n
`
`ileptic
`69
`EE=ETre
`
`ders
`
`by
`
`lCJ:%>:G. C. A
`e
`omas.De
`stimulat'
`I’
`
`p I
`
`An ove
`nd neuro
`
`3'_"O1'U""(D
`NCDD):
`
`:5
`
`2 r
`
`a
`f
`
`on,WERNICKE at
`
`F. S. Prato, A. W.
`ion.vaga|
`n
`nial
`stimul
`
`r t
`
`t a
`
`t
`
`l'S
`
`ion paramet
`ease.Neuroscien
`
`and Biobehavioral
`
`CD
`
`ews 33(2009)
`
`10
`
`<co
`—1060:GROVES DA,Brown VJ.Vaga| nerve st
`mulation
`review of
`its applications a
`
`3-500;Reese TERRY,Jr.Vagus
`tion:a proven therapy 1‘
`
`ne
`
`pilepsy strives to impr
`
`o o
`
`09(9me
`
`d potenti
`clinical
`
`that mediate its
`| mechanisms
`ffects.Neurosci Biobehav Rev
`
`9(2005):4
`|
`ve sti
`tment
`
`rn
`
`rn
`
`rn
`
`rn
`
`oar-#3903
`
`coca-(03+:
`
`d expand applications.Conf
`
`Med Biol Soc.2009:2009:4631—4
`
`y B.MAPSTONE.Vagus nerve s'
`
`rrent conceptS.Neurosurg F
`
`)E9,pp_1~4; ANDREWS,R.J.Neurom
`
`
`
`(7)
`
`JP 2017- 518857 A 2017. 7. 13
`
`tion.l.Techniques—deep brain stimul
`
`,vagus nerve stimulation,and trans
`
`al magnetic stimulation.Ann.N.Y.Aca
`
`DJ 3
`
`0 -"‘DD)
`
`993(2003):1—13:LAB|NER.D.M., Ahern
`in
`L.Vagus nerve stimulation therapy
`
`ession and epilepsy:
`
`therapeutic par
`
`er settings.Acta.Neurol.Scand.115(20
`.23—33)::
`
`008]
`
`Fl-
`1
`
`0.0030
`fioma~
`
`Efillié'ifi'fiafifififififi.Bjaficii'dé’r<l:ib'f:0‘c. —H*_—"'|T:"J’J>tt< 3:1515
`EQEET$U%DEEfiEHfiE$®m®EfiEEEEEEE5Ahtfififl.Efifi
`
`10
`
`Efififim.Efififififiwifléfle?6(eert B.VARGAS, Davi
`d W. Dodick. The Face of Chronic Migrain
`
`e: Epidemiology, Demographics,
`
`and Treat
`
`(2009)
`ment Strategies. Neurol Clin 27
`67-479; Peter
`J. GOADSBY, Richard B. Lip
`ton, Michel
`D. Ferrari. Migraine —Curre
`
`4
`
`nt understanding and treatment.
`
`N Engl
`
`Med
`
`346
`
`(4.2002):
`
`257— 270; Stephen D
`
`J
`
`S
`
`ILBERSTEIN. Migraine.
`3 81—3 91 )
`o
`
`[0009]
`
`LANCET 363
`
`(2004)
`
`20
`
`H'Efifili. fiflfi'inlat.
`
`‘H‘fififififi.
`
`151135. fife. BLU.1£%E#¢®E§BE’E$§%. in“:
`
`mfifwfifififib‘r‘\fbfi§%flij’étwfili73<‘ §F§E§®RfiiUitlfi$§bUéEEflTé
`
`%¥HE<.W%®W%£EU%6°10®Hfifififimfififififimwfififififiwfi
`SEEKtEEBEmBEU.
`fil’lfififlwfiflflfib‘ifi%filfilzfi< ..
`
`[0010]
`
`fi‘u‘SEfilb'tlzt.
`
`fififiliélslfitflfi< é‘fil‘flEfi’Efifi'en fi‘iifilififllfili.
`
`“HEGDE'ERCDEFI'EE‘
`
`3E???
`
`.fifi\E%fl\fififi\M59E.&U.flgfiflfififi%ézt#%mofifimzb
`
`blitmfl%§¢%®gfi(%%Efitefieh%)m\fifi.%¢®9m<t£48
`
`fifiiUflKiUéofiflfifi®$fl%fifififim.6b510fifiTfiéfi.Hfifim
`
`%1’F0)ilifili‘
`
`fifififififitfiZ Belt-3:11”) ’ijal< ( ilei‘ fit) ”635“). Hfifiwfil’liwfii‘]
`
`1 5%11.
`
`fififififillfifi. 12E|§Féi7$52 Eli:=bT:-:'tfifi< .
`
`[0011]
`
`1E
`311351;. HEW‘GGJEES‘JKfi‘lEEDELCJiéc Hfififififimifi’g2o ~3 0%7b". fifili.
`fififi%fi%%fi%éfi$bffiu.Cnm\fifimfififli%fifififi(fifif7®5
`
`4V) tbffifié‘é‘ii‘néo LJD‘L~ Jailaiiéfifili. %®fi3?$§llfl‘fl‘b5?"\
`
`fififiFafiEiUE
`
`$b‘fifib‘lbfifilC. EilfilDifiATtifi<§itiéu
`[0012]
`
`fififlfim.flfifiefiiéfi.fie—flmflm.fifififlflfittfifi.fimfiat
`
`LT%$%OC®%.mfiflfifififififikbtfi%\fia#¢fleifitb1§fi$h
`
`éE—Olcig'fi'éc Hfifilit ¥l§¥TlJ§E®filfifllC$06Ct7J‘5él.\7b“. Hlfiu-fiwfiaw
`
`kAmNé—ym.efiflufineztfiem.zmfiae.fififl/fimfifiefifib
`
`Tfillfifififilfiflfififi‘c‘;Eétififié‘héit#155er HEPE‘G.
`
`IEWH‘J’JS'jJ'GElbLM $36
`
`mafiflflfifififiéfifiwfilfifififiéo fiamfififl‘é‘lat.
`
`jCAT4~7 2 Biffiafi. ¥létti1~7
`
`2 Efifivflnfifi.
`
`filififififififififiFfllat—EQH‘JIC1 ElézUtJ’JJtMAO fiawafiélat.
`
`557%".
`
`filii'é'
`
`l,‘ fifliflfi’d'éfi'fi‘l‘oflfilfifiéka‘én Efibifiiifibfzifi‘ %< ODEE%I.:1~2 Elfii’a—l’fé
`
`%%Eflfifiéofiflfifi¢®$téfififi.E%Wfi%%®%fifififififiée
`
`[0013]
`
`fiEfi/flfifififl$éfifié%fiiétwmfifififlfiiwfiflfléfifiiéifiw
`
`30
`
`40
`
`50
`
`
`
`(8)
`
`JP 2017- 518857 A 2017. 7. 13
`
`ctUE‘a'HfifliEfifi‘lEiEli.
`
`Ifillfilfifi‘t‘. $fiflflwfig§AlC§§ififihtfljJ§E§v§US1 3 /1
`
`09,250.®%§%U820110230701.$%FEIectrical
`nd magnetic stimulators used to treat
`
`a
`mi
`
`grains/sinus headache and comorbid disor
`
`dersJSIMON5E$6.&0.mfi§%U313/183,721.fififieu
`820110276107.§§EEFE|ectrical
`and magnetic
`
`stimulators used to treat migraine/sinus
`headache,
`rhinitis, sinusitis,
`rhinosin
`
`usitis,
`
`and comorbid disordersJSlMONBlzazé
`
`Efififi?éfi\§fib'd.
`sens.
`
`[0014]
`
`(111.6%. 356*436EB‘JlCi‘a‘l/‘Cfifln'fi'éitltctkl. é‘illiifi’a
`
`aflfim.fififidEfiwa%Wfifiufiiefiawfifimswseflfifieemfifi
`
`ugfi<fimefiteeoafim.fitnflfibkfifim$¥&vfifi(—fimfiflfifi
`).aa¢ewaaavsaem(efiemee).aaeexawmemaae.ma
`
`1:. EfisflfifimmmzDELLCDISEEtfififij'etfiiz. fibhé. s’z‘flfiii.
`
`till-3311i.
`
`1i
`
`asymee.eaeeeat.ee.eetme.mmaeeea.traeeev4
`
`wzaeueetsaaee.meeamaws,aa.emaaem.%aeawna
`
`%fi%%@%®—fltae%EWK%%E%EE%%%vte.fists§m(McKH
`
`ANN G, Drachman D, Folstein M, Katzman R
`, Price D, Stadlan EM. Clinical diagnosi
`
`the
`of
`report
`of Alzheimer’s disease:
`s
`NINCDS—ADRDA Work Group under
`the auspic
`
`of Health and Human Ser
`of Department
`es
`vices Task Force on Alzheimer's Disease.
`
`Neurology 34(7,1984):939—44: David S.
`NOPMAN. Alzheimer’s Disease and other
`
`K
`de
`
`mentias Chapter
`
`409
`
`(pp.
`
`2274—2283)
`
`Goldman’s CeCII Medicine,
`
`24th Edn.
`
`In:
`
`(Le
`
`Schafer, Eds.).
`e Goldman and Andrew I
`Philadelphia
`ElseVIer—Saunders,
`2012;
`
`B Alzheimers Disease: Compre
`THOMPSON S
`hensive Review of Aetiology, Diagnosis,
`Assessment Recommendations
`and Treatment
`
`. Webmed Central AGING 2011; 2(3): WMCOO
`
`1681.
`
`DD.
`
`1—42)0
`
`[0015]
`
`fimfififi$a,71~79$®5%#590:M:m37%it.fifitfitex?
`
`a. Lift. %tfiwfifi$izfifib5f. 7Jp'yrx4v—issmsamficzt.
`
`flumififit—fi:
`
`FA, Davi
`E, Schmitt
`‘C'iatti:1,\(NELSON PT, Head
`5
`PR, Neltner
`JH,
`Jicha GA, Abner EL,
`Sm
`
`ith CD, Van Eldik LJ, Kryscio RJ, Scheff
`SW. Alzheimer’s disease is not “brain a
`
`and e
`ging”: neuropathological, genetic,
`pidemiological
`human studies. Acta Neuro
`
`pathol
`
`121(5,2011):571—87)°i§ifi¥i$.$%§30)AD(/7
`
`—zm1%*%)caaeekt.JU—emaAwaacwasesemaeeme
`
`mflem.APOE e4§fi¥fiau.tw1aitd§fl®:E—eeafi§mAu
`
`1O
`
`20
`
`30
`
`4O
`
`EaHeADE%®60%fifiorueo%5tauae\ADwfifim,fivxwwfl
`e.eameafie.wmeee.eafiaamengotemtazafias.
`
`50
`
`
`
`(9)
`
`JP 2017-518857 A 2017.7.13
`
`[0016]
`
`fiflfiwfifltmsigflfi%m\sjmwfifififi(7»VA47—fi\vE—mw
`
`fitWEMEEEHE)fiUWMEfiET$§OflaTflt7wvn47—fifit%flfi
`
`m7—2®%7O%E£w\m%fi%mfim.7—2w17%%fim?%0uE—m¢%
`
`fififififififlfifififififi\#—1®%U®13%&‘hiU—flfl?flufifl(fli
`fit7wz—wmefi/¢E%EE\flefifififi‘EfiEmfifi.N—sy9yfiafl
`
`fi‘0u497lwh-VJ7fi.RU‘$$fifi)t#E£ménmfififiu‘fi54
`
`OEm7fiUflAfifiE‘7wvn47—fiéfliTifibtW1SOE®7XUflkfi
`vE—wfiflfififingfinfuen
`
`[0017]
`%n%n®547®%mfi®%%m‘fitwflflmmfifiéfita7wvA4?—fi\
`
`cutmfifieEfifiinfififieutfifiwfiifiuiuesfiwfikmfifieim?
`
`zafi‘éfiJmfiEiT-‘ipzao I/E—rhfiiizctés’aiflfiii‘ z\°—=F‘/‘/‘/:1“L\‘ 2315? EUR l/
`
`AEEE§KJU\fifidwenéofiEMEfifififim.EfiofiflfivAfifimn;
`U‘itu.:wfiiwmfiE%an%Efiatéfififitiu‘fiflfiwehéufl
`
`m%%%flfiw‘T?n—Afiflfi§kfi®%fifimitfi%U.fifififiwfiflfihé
`
`Mmfifiw1vikmfifi®ME§(EMHMfi§)Essswcfiéemfiflaflfie
`#57wvn47—fimfififiEH‘—$WTEU‘Zhém23®%fifiéfifimam
`
`Edmtzwisztmafimztfieso
`[0018]
`
`fifihfiflktawfikTécts‘fimfiwAfifiictfieeoLkfiot‘fifl
`
`fissmfifiAm\—fimu%%fiflmbiEflfigumutévfifififistumwa
`
`Kfififi$flfifififlfitTéztfifiéztKLfiLfifiH<a:thhbWéfifi
`
`Efimfifififififivfifimfimui:wsfieafiéfifisstwufifiéntfififi
`gfififimbt\fimfiwiamfifiemfiezfitemEEEtteatfibe(Ea
`mfifimfifi‘1amgflflfigfi‘x4a—EE§EE)ObE—mwnssfiwfim
`
`\—emmaesmmeautseueeu\senesssnemssnfim<‘fim
`
`tt%<M&fiE®55E‘fifiuswmfifimfi<iffiaafifimu‘7»9n47
`
`—fiuswe%fi§flm\fififlnflfifififi%fi%nEWEiififlfififishe:t
`
`fi§<tfiflmcmte%uawefiUfiL‘fifiwafiitusfitfitemfih‘i
`
`km\Efiflfifiu$6fl®fifltbffihéo7»vn47—fi®%%flawé%fifi
`
`flwzwfifimfififififim‘%bt97h?6$Ut‘$Ufifibtfi§f97h(§
`
`L\Ei/EL\EI)?6:t75\’%L\°
`
`[0019]
`
`10
`
`m
`
`30
`
`fiflfifiwxhlxhfi‘bE—$¢EiéfififiE—Efiflflfiwfi47‘itfi‘
`7wvn4?—%%KH—fiwcauaama4dflromtsmfnsfientumuo
`
`wa.:®xn:xbe\raeneefiisemawfisueesnsswtums
`
`#Kfifibffiutznm.%fififlfi1B®%E®%E®EUT%$?6%E#EMF
`
`BT55” Efiéfilfigjmxnlehffflfifiafitt‘ Efiiifiwifiéflwflfi%lcfial§é?%l¢
`iutEflTéfififlfiEEEfifi?6lhb2fi§fifififi¥%fifihé$5fi.%h
`E?%Wikfifififi$tbrma®%ecst%n&m¢itm%tatficsect
`
`w
`
`fifimffifififié(Jorge J.
`
`PALOP,
`
`Jeannie Chin a
`
`A network dysfunction
`nd Lennart Mucke.
`perspective on neurodegenerative disease
`
`WALKER
`3. Nature 443(7113,2006):768—73;
`MP, Ayre GA, Cummings
`JL Wesnes K, McK
`
`CI
`eith IG, O’Brien JT, Ballard CG. The
`nician Assessment
`of Fluctuation and the
`
`T
`One Day Fluctuation Assessment Scale.
`wo methods
`to assess fluctuating confu“
`
`W
`
`
`
`(10)
`
`JP 2017- 518857 A 2017. 7. 13
`
`on
`
`in dementia.
`
`Br
`
`J Psychiatry 177(2000
`
`M
`BRADSHAW J, Saling M, Hopwood
`252—6;
`)
`, Anderson V, Brodtmann A. Fluctuatlng c
`
`ognition in dementia wuth Lewy bodies
`
`an
`
`ely d
`d Alzheimer's disease is qualitati
`istinct.
`J Neurol Neurosurg Psychiatry 7
`
`O’
`5(3,2004):382—7; BALLARD C, Walker M,
`Brien J, Rowan
`E. McKeithI
`The charact
`
`’fluctuating’
`of
`Impact
`erlsatlon and
`gnition in dementia with Lewy bodies
`
`co
`and
`
`Alzheimer’s disease
`
`Int
`
`J Geriatr Psyc
`
`Fl
`JL.
`494—8, CUMMINGS
`hiatry16(5,2001)
`uctuations in cognitlve
`unction in deme
`
`ntia with Lewy bodies
`
`Lancet Neurol
`
`3(5
`
`John—Paul Tayl
`LEE,
`,2004) 266; David R
`or, Alan J
`Thomas. Assessment
`of cognit
`
`ive fluctuation in dementia
`c
`review of
`the literature.
`
`a systemati
`Internationa
`
`|
`
`Journal
`
`of Geriatric Psychiatry 27(10.
`
`“S
`P.
`BACHMAN D, Rabins
`2012): 989-998;
`undowning”
`and other
`temporally associat
`
`ed agitation states in dementia patients
`
`. Annu Rev Med 57(2006):499—511].
`
`[0020]
`
`sfimfifimfiflwflfififim N4jv—hsfimss.cnm.AD%®%fifiw
`fih%TTfi%TM£T%Q£fi $E$.$t$&flfl%$fi§fi?b%.ADfiwfi
`
`t—flfififilzififlmfih6A417—flll.Hfi§%fi(CSF) PHONE—FLEA 842‘ 1st
`
`LtCSFsd.PETT®fiFLt7»1D¥1$97»:—XWW(FDG—PET
`
`).PET7$D%FE%M.&U.M§%E®EE mMRlfifiéét AD&E%5
`
`Hi'éfcabmn‘ler—fiwfififili‘ flimsy? EfififiwflEEE—EZ‘A’ij—flfifimfilfifi
`
`Eflf4/ Ficfifi%i‘ hT:(MASDEU JC, Krei sl WC, Berman
`
`KF. The neurobiology of Alzheimer disea
`
`se defined by neuroimaging. Curr Opin Ne
`
`urol 25(4.2012):410—420, DUBOIS B, Feldm
`
`Jacova C, Dekosky ST, Barberger—G
`an HH,
`ateau P, Cummings
`J, Delacourte A, Galas
`
`S,
`ko D, Gauthier
`rien J, Pasduier
`
`Jicha G, Meguro K, O’b
`F. Robert
`P, Rossor M,
`
`Salloway S, Stern Y, Visser PJ, Schelten
`s
`P Research criteria for
`the diagnosis
`
`of Alzheimer’s disease
`
`revusing the NI
`
`NCDS—ADRDA criteria. Lancet Neurol 6(8,2
`
`dm
`Fe
`007):734—46; GAUTHIER S, Dubois B,
`an H, Scheltens P. Revised research diag
`nostic criteria for Alzheimer's disease
`
`Lancet Neurol
`
`7
`
`(8,2008)
`
`668—670)o
`
`[0021]
`
`zossgnfimfisfifis HEi'iEEGJADGDSJa‘ fijiii'i’é Eflfiflj'éo Zilliflflfi‘fl'éiifi.
`
`chem,ADe%®%mWEkE% $163? RU Aowfifiiflemfifiéefi
`
`ifilt éfililj'éjiifiéflfiTé MTlCEIFfi?6"$ElC§E§Z®73—ifili. ADUDEWUD
`
`
`
`(11)
`
`JP 2017- 518857 A 2017. 7. 13
`
`aosauswaxsusssaammsusxsasmsaatsuaabrasf.
`
`ADwfifiéfimtatmwfifififlenruaukm.fiMofiafiflgtsnact
`mmaaraa.fifimafiitsfiefifiwfimflmmfifixB;fi.%®fi%mfi%
`
`lcclet LXFGDSCWHJ.
`[0022]
`
`:TLBOD‘E-EfilcfififiéL/‘CBU. mrosmfiafilfisn‘cua.
`
`AD®EEEhE7$E4FfiR7—Ffifi(Rfifwfimfifiwgfi)wfim.AD
`
`fi%m%sm.ADfifimmfiufiisnaWfifl$mfifiéfiaztabu.chm.
`
`N—syvyfimpfiFNfifimfiwaaeflwtfifififiimfifimfifia%fibto
`
`2655c. Zhl:J:U. 7JI/‘yA47—fiGDZIU Vlfiéil'lilfiéfibiisb‘n\ Chis.
`
`fififllfiEE
`
`auawaauywflfi:1—uymfifiaswiMEfifimmfifiswaUyWflfiW
`fififimfifitéfififi.7wvn4v—fifiaufienafifimfiwfimes<Em
`
`?6CtEfiNTU6°f®fi%fi5$0kfififi¥%%fifi\f®%%%#%E$$¢
`
`0T.fifififimfifiéfiafiebwotflufltflfibaf‘EEQADflfiwifiT
`
`fiU¢flTEéoAD®fififi%fififififi\WEEEME-7t¥wflinkmfiw
`II
`9‘yflfiwmfhbéfifi.DaU.:UyIX?5—Em%$(5ouy.Uflzf
`I
`fiq‘ . fiayssyaszfisasvw) Ettfiifi—vvJI/NifJb—D—Tzlifiat’yfl
`
`La
`fifi¥(XVV}7)?%§(FRANCIS PT, Ramirez MJ,
`i MK. Neurochemical
`baSlS for
`symptomati
`0
`treatment
`of Alzheimer’s disease
`Neur
`
`FRA
`opharmacology 59(4—5,2010)221—229,
`NCIS PT. Palmer
`AM. Snape M, Wilcock GK.
`
`The cholinergic hypothesis of Alzheimer
`
`’3 disease:
`
`a
`
`review of progress.
`
`J Neur
`
`ol Neurosurg Psychiatry 66(2,1999):137—4
`7; MESULAM M.The cholinergic lesion of
`A
`
`Izheimer’s disease: pivotal
`
`factor
`
`or
`
`si
`
`de
`
`show? Learn Mem11(1,2004):43—49)°
`
`[0023]
`
`7t}»flUVEEH7»95Vflmfimfifififiwgéfi%?éltflié.AD®
`
`fififiis%§snrsto%®¢5fl%fifiémfifijwlea7Uy(2w7sb1
`
`'J ‘2) (NEH. Chlifllfimlcta‘u‘t. Ilcfifii‘céfifishéo / JbIlifu<7'J‘/Lz/\°JL®
`
`fififififiwtmwflmfifimm.ADFfi‘fififif/w7FVTUVWEEZJ—D
`
`s
`yfifikb.fbrfifim.%®E%&fifiaaztfiaa(HAGLUND M,
`jobeck M. Englund E. Locus ceruleus dege
`
`di
`neration is ubiquitous in Alzheimer's
`sease: possible implications for diagnos
`
`is
`
`and treatment. Neuropathology 26(6,20
`
`06)
`
`528—32;
`
`SAMUELS ER. Szabadi
`
`E
`
`Funct
`
`10
`
`20
`
`30
`
`the noradrenergic
`Ion I neuroanatomy of
`locus coeruleus:
`its roles in the regula
`
`4O
`
`tio
`
`art
`
`of arousal
`
`and autonomic function p
`
`ll
`
`physiological
`
`and pharmacologica
`
`lmnlpulations and pathological alterat
`i
`ns
`of
`locus coeruleus activuty in huma
`
`254—85
`Curr Neuropharmacol 6(3,2008)
`n
`,PatriCIa SZOT. Common
`factors among
`AI
`
`zheimer's disease, Parkinson’s disease,
`and epil
`psy
`Possuble role of
`the norad
`
`system EpllepSla 53(Su
`renergic nervous
`ppl
`1,2012) 61-66).,
`
`50
`
`
`
`[0024]
`
`H3
`
`JP 2017-518857 A 2017.7.13
`
`Eckert,
`
`Norepinephrine in
`
`Lkfiot.fifi®fi%%m\
`ADfia‘wiafit L‘Cflfip‘s/ JbIE$7 U yéisfluié
`K
`H
`AZEY,
`V
`:téfifibt(EM V
`inson,
`AC Granholm
`MA
`GA Jones.
`A
`
`Coerulean Target.
`
`nsonism 2(2,2012)
`
`Neurodegeneration
`Alzheimers
`Dis Parki
`o
`1000e1 14,
`—Jb73 ytlfifilc.
`
`J
`
`p
`
`D. 1-3)
`/»Iea7uysmamansaassamtw.emaaam
`
`J»IE*7UyEW®E5H,mwn;3
`
`awa%®pswaemststmwfiatLtfififlficaam.%®$5m7y71
`
`95 vascttfx aLJII7I:7_:—I‘ 73350354< wiflmfiiials.
`JJI/Il:°$7'J‘JUJHi$iI7EIL/’\°
`‘E’Il'bliali‘
`”78193111131155: 8: b‘TfiéfiV
`iflwfifilfifimfivzihl:%%afiiib.
`
`EififififléfiT6o fwfifitbf.
`
`suwauaasa.¢maasuswéxw
`
`154%le Vl/NJl/Ei'éflflfifi‘ its,
`
`T F lx—f'J Vl’FElJ’li‘Evfi'jLJlulfiEéiEElb'é'é
`
`Hatbtfimsn.and,Eisntusozmem.zwlea7uythfiw
`
`afiflafimteztaaab,chm./»IE$7UymfifidtLthb.J»
`1617'} VODEEEUiAzfiirjEI‘yOL. JJLIE$7Uymfiidjéiaifij'éTFl/T'J
`
`De
`R,
`fifiwgfifitLTWmié(MlSSONNlER P, Ragot
`ouesne C, Guez D, Renault
`B. Automatic
`
`ttentional shifts induced by
`
`a noradren
`
`rgic drug in Alzheimer's disease: evide
`ce
`from evoked potentials
`Int
`J Psych
`
`FRIEDMAN M
`physiol 33(3,1999). 243-51;
`Adler DN. Davis
`KL
`The
`role of norew
`
`cogM
`in the pathophy3|o|ogy of
`ephrin
`ive disorders: potential applications t
`
`the treatment
`
`of cognitive dysfunction
`
`in schizophrenia and Alzheimer’s diseas
`
`1243—52;
`. Biol Psychiatry. 46(9,1999)
`ALININ S, Polak PE, Lin SX, Sakharkar
`
`A
`
`, Pandey SC, Felnstein DL
`
`The noradren
`
`line pre ursor
`in a mouse mod
`
`reduces pathology
`L—DOPS
`I
`of Alzheimer’s disease
`
`Neurobiol Aging 33(8,2012):1651-1663;
`OHS. R.C.. Shlovitz,
`T M.,
`Ta
`iot,
`P.N
`
`Porsteinsson, A.P.,
`
`B ker, K.D., Feldm
`
`n, P.D..
`
`2009 Atomoxetine augmentation
`
`therapy in
`itor
`f cholinesterase inhi
`atlents with Alzheimer disease
`8—month
`
`randomized, double—bllnd, placebo—cont
`
`oiled, parallel—trial
`
`study.
`
`Am.
`
`J. Ger
`
`atr. Psychiatry 17, 752459,
`
`SCULLION G
`
`D, Par
`DA, Marsden CA, Sunter
`||
`, Kend
`on MC. Chronic treatment with the a2—ad
`
`enoceptor antagonist
`
`fluparoxan prevent
`
`age—related deficits In spatial workin
`
`memory
`
`in APPXPSl
`
`transgenic mice with
`
`ut altering B—amyloid plaque load or
`
`as
`
`rocytosis. Neuropharmacology 60(2—3,201
`
`):223—34)o%fifi®%flEflLT‘/»IE$7be&wEEE?ét%
`
`enruammfl¥nu.fifizhb1.Efi7mymafi.&0,fi50%fifias
`
`1-.
`
`Afiommfigbm
`
`i
`
`m
`
`m
`
`m
`
`w
`
`W
`
`
`
`(13)
`
`JP 2017- 518857 A 2017. 7. 13
`
`11%;(NESTLER EJ, Alreja M, AghaJanian GK
`Molecular control
`of
`loo 5 coeruleus neu
`
`rotransmission
`
`Biol Psychlatry 46(9,199
`
`and Szabadi
`E R.,
`SAMUELS.
`9):1131—1139;
`,
`E. Functional neuroanatomy of
`the nora
`
`drenergic
`
`ocus coeruleus:
`
`its
`
`roles in
`
`and autonomic
`the regulation of arousal
`function part
`II
`physiological
`and pha
`
`rmacological manipulations and patholog
`ical alterations of
`locus coeruleus acti
`
`1O
`
`vity in humans
`
`Curr Neuropharmacol
`
`6(
`
`2008),
`
`254-285)..
`
`[0025]
`
`b#L\Efl®Emu$U.fiflimufigsnt/»Iaa7uywfim‘ska.
`
`mmwaacsws7spiupeasanasvdT»EEwemfieamquas
`oruaicasctm. FEE—shrufdzmn $3”. ADEE'aS’C‘li. 7E1:~‘/"/( EPilZl’Em?
`
`w7727FpTUy7j:2h)mfiflfififl$¥afifisnmct\fifi.fifiWE
`
`Eataafiéfinaatnfiaazt.fiflasntommfifiu.7w772—7H
`
`pfuy§§%7j:2b.77y779ym.fififlfim§§bnwztE—ELTE
`
`‘d'n bfcifio'c‘ 0n:~‘)‘/$Tclid?y779y®§~£5li. EfitfitfifiifcliADfiL,
`
`(mmwfimfiafifi1é%%®mfhfit.fiflfifimawafifimfi¥flfl§fififi
`
`tsaiufiitmo—fi\7»772—7Kv+Uy§$W%fi$.4§V$fiym.
`
`%E\fifififi§\%fifi5;5fi.KU.IEv—Ffifiéflfibtfi.fifififl¥fl
`
`fififiEBHéEEO—$y7XEUEfiUk(MARIEN MR, Colpaer
`t
`FC, Rosenquist AC. Noradrenergic mecha
`
`nisms
`
`in neurodegenerative diseases:
`
`a
`
`t
`
`heory. Brain Res Brain Res Rev 45(1,2004
`
`):38—78)n
`[0026]
`
`fiat.leaa7uym.Aofifitawaflgfid$fiéxs<gmsfi.Lt
`b‘o't.
`istflbfc/ JDIE$7 'J
`:2 Lz NJl/aalicfiwifiz‘ifi’gfxflfib".
`fiflB’JEUl’EfiiEzzfirb
`
`mg¥wfl¢mfl$jffiflfihéztfiE%(HERRMANN N.Lanctot
`KL.Khan LR. The
`role of norepinephrine
`
`in the behavioral
`
`and psychological
`
`symp
`
`toms
`
`of dementia.
`
`J Neuropsychiatry Clin
`
`Neurosci 16(3,2004):261—76;
`
`PESKIND,
`
`E
`
`R
`
`,
`
`, Tsuang, D.W.. Bonner, L.T., Pascualy
`
`M
`
`. Riekse. R.G.. Snowden. M.B.. Thoma
`
`20
`
`30
`
`s, R., Raskind, M.A
`sruptive behaviors
`
`Propranolol
`In nursing home
`
`di
`for
`resid
`
`4O
`
`ents with probable or possible Alzheimer
`
`disease
`
`a placebo—controlled study.
`
`zheimer Dis Assoc. Disord
`
`19(2005):
`
`AI
`
`23
`
`48)u
`
`fiSK.ADKBH6%flMMflwE%m.mwmflnswé1»16$7Uymfifi
`
`$EEDE§§Z€§%U\Lkfiof‘WAflwAD§%®/»IE$7UVVNN#
`
`filfil:i§flflfl'éifitfidfié(Fitzgerald PJ.
`
`ls elevated
`
`in
`factor
`norepinephrine an etiological
`some cases
`of Alzheimer's disease? Curr
`
`50
`
`
`
`(14)
`
`JP 2017- 518857 A 2017. 7. 13
`
`ELROD R,
`Alzheimer Res 7(6,2010):506—16;
`Pe kind ER, DiGiacomo L, Brodkin KI,
`Ve
`
`ith RC, Raskind MA. Effects of Alzheimer
`
`’s disease severity on cerebrospinal
`id norepinephrine concentration.
`Am J
`
`flu
`P3
`
`ychiatry154(1,1997):25—30)o
`
`[0028]
`
`ADKBHééfiWEMW/»IE$7Ubewmflwfifijttbffi,:mfi?
`
`m.%TL£§EE$31E$$htwfifi®¢Efi—E%$?%£@THE<\fififi
`
`fifimfia—ymfime.Mmflcéfifim/w7Hv¢UyWEE§EWfijy47®
`
`’J/‘Rtfi‘é'ljfl‘c‘. EElb?%Ctb‘°%§(HOOGENDI JK WJ,
`emu/973:;
`enstra MG, Botterblom MH, Gilhuis J,
`
`Fe
`Som
`
`mer
`
`IE, Kamphorst W, Eikelenboom P,
`
`Swaa
`
`Increased actIVity of surviving Io
`b DF.
`cus ceruleus neurons
`in Alzheimer's dise
`
`ase. Ann Neurol 45(1,1999):82—91;SZOT P
`, White 88, Greenup JL, Leverenz JB,
`Pes
`
`kind ER, Raskind MA Compensatory change
`
`sin the noradrenergic nervous
`
`system in
`
`the locus coeruleus and hippocampus
`
`of
`
`postmortem subjects with Alzheimer’s dis
`
`ease and dementia Wlth Lewy Bodies.
`
`J Ne
`
`urosci 26(2006):467-478;
`
`SZOT P, White S
`
`S,
`
`Gr
`
`enup JL, Leverenz JB, Peskind ER,
`
`Raskind MA. Changes
`
`in adrenoreceptors I
`
`n
`
`the pretrontal cortex of subjects with
`
`dementia
`
`evidence of compensatory chan
`
`ges.Neur050ience146(2007).471—480).
`[0029]
`
`Lkfidf,figtéhfifiwfi,ADfifi®¢fiHfi$éfiEJm1€$7beN
`
`weeEflnemseseeeMEgema<.estsnsemvos.emwc,z
`
`)l/IE’$7'J Vl/NJbEiElJIIH shined») secta<csefifi5faae. Zhli‘ ’60)
`
`Em5%fifléfl%?6:téfimtaufig.std.%®/»1€$7prswm
`
`%M#,AD%%®wmflfiitéfi%$fl$mflm%m¢b,Efietitmfifiéfl
`
`a:téfi@?eufi¢.§$cfié.(COUNTS SE, Mufson EJ
`Noradrenaline activation of neurotrophi
`
`c pathways protects against neuronal
`
`amy
`
`loid toxicity.
`
`J Neurochem113(3,2010)
`
`6
`
`49—60; WENK GL, McGann
`
`K, Hauss—Wegrzy i
`
`ak
`
`B, Rosi
`
`S. The
`
`to><icity of
`
`tumor necr
`
`osis factor—alpha upon cholinergic neuro
`ns within the nucleus basalis and the re
`
`the regulation 0
`Ie of norepinephrine In
`f
`inflammation'
`Implications for Alzheim
`
`(3,2003).7
`er’s disease. Neuroscience 12
`19—29; KALININ S, Gavrilyuk V, Polak PE,
`
`R, Zhao J, Heneka MT, Feinstein
`Vasser
`DL. Noradrenaline deficiency in brain in
`
`creases beta—amyloid plaque burden in an
`animal model
`of Alzheimer’s disease.
`Ne
`
`
`
`(15)
`
`JP 2017- 518857 A 2017. 7. 13
`
`1206—1214; HENE
`uroblol Aging 28(8,2007)
`KA MT, Ramanathan M,
`Jacobs AH, Dumitres
`
`cu—Ozi mek
`
`L,
`
`Bi
`
`| kei —Gorzo A, Debei r
`
`T,
`
`S
`
`astre M, Galldiks N, Zimmer A,
`
`oehn M,
`
`M.
`T, Staufenbiel
`Heiss WD, Klockgether
`Locus ceruleus degeneration promotes Alz
`
`heimer pathogenesis in amyloid precursor
`
`protein 23
`
`transgenic mice.
`
`J Neuroscn
`
`1343—54: HENEKA MT, Nadrlgny
`26(5,2006)
`F, Regen T, Martinez—Hernandez A, Dumit
`
`D,
`rescu—Oznmek L, Terwel
`utz D, Walter
`J, Kirchhoff
`
`Jardanhazi—Kur
`F, Hanisch UK
`
`, Kummer
`
`MP
`
`Locus ceruleus controls Alz
`
`heimer’s disease pathology by modulating
`
`microgllal
`
`functions through norepineph
`
`rine
`
`Proc Natl Acad Sci
`
`U
`
`S A. 107(13,2
`
`6058—6063,
`010)
`mmer MP, Terwel
`
`JARDANHAZI —KURUTZ D,
`D, Vogel
`K, Thi el
`6 A,
`
`Ku
`He
`
`neka MT. Distinct adrenergic system chan
`
`ges
`
`and neurOI
`
`flammation in respons
`
`to
`
`induced locus ceruleus degeneration In
`
`APP/PS‘I
`
`transgenic mice. Neuroscience 17
`
`6(2011):396—407,
`
`YANG JH, Lee EO,
`
`Ki
`
`SE
`
`Suh YH, Chong YH Noreplnephrine diffe
`,
`rentially modulates
`the Innate inflammat
`
`ory response provoked by
`
`amyloid—B pepti
`
`de via action at B—adrenoceptors
`
`and act
`
`ivatlon of
`
`cAMP/PKA pathway in human
`
`THF’
`
`Exp Neurol 236(2,2012)1
`—1 macrophages
`99—206,
`KONG Y, Ruan
`L, Qian L, Liu X,
`L
`6 Y. Norepinephrine promot
`s microglla t
`
`rade amyIOId beta peptid
`o uptake and de
`e
`through upregulatlon of mouse
`f
`rmyl
`p
`
`eptide recep or
`
`2
`
`and Induction of
`
`insul
`
`J Neurosci 30(35,20
`in—degrading enzyme.
`12):11848—11857, KALININ S, Polak PE,
`Li
`
`n
`
`SX, Sakharkar AJ, Pandey SC, Feinstein
`DL
`The noradr nallne precursor
`L—DOPS
`
`educes pathology in a mouse mod
`
`I
`
`of
`
`AI
`
`zheim r’s disease. Neurobiol Aging 33(8,
`
`51—1663, HAMMERSCHMIDT T, Kummer
`2012):‘l
`MP, Terwel
`D, Martinez A, Gorjl
`A, Pape
`
`HC, Rommelfanger KS, Schroeder
`
`JP, Stol
`
`M
`eka
`H
`D,
`M, Schultze J, We nshenker
`|
`T. Selective Loss
`of Noradrenallne Exace
`
`rbates Early Cog
`
`Itive Dysfunction and S
`
`P
`yn ptlc Deficits in APP/P81 Mice. Biol
`sy hiatry.
`2012 Aug
`9. Epub ahead of pri
`
`1—10; O'DONNELL J, Zeppenfeld D,
`pp.
`nt,
`McConnell
`E, Pena
`S, Nedergaard M Nore
`
`
`
`(16)
`
`JP 2017- 518857 A 2017. 7. 13
`
`pinephrine:
`
`A Neuromodulator That Boosts
`
`the Function of Multiple Cell Types
`
`to
`
`Optimize CNS Performance. Neurochem Res
`
`2012 Jun 21.
`1—17),
`
`[0030]
`
`(Epub ahead of print},
`
`pp.
`
`fifififl£\59fi\fig.RU,fifiE?%®AD®:RWEfiE%fiiékwu.
`
`fifiEEWfiwfifimfitfi$fibfiffi§éhtué(Julius
`
`POPP an
`
`treatment
`d Sonke Arlt. Pharmacological
`of dementia and mild cognitive impairmen
`
`t
`
`due
`
`to Alzheimer’s disease. Current
`
`Op
`
`Fa
`union in Psychiatry 24(2011):556-561;
`di MASSOUD and Gabriel
`C Leger. Pharmaco
`
`logical
`
`treatment
`
`of Alzheimer disease.
`
`Can
`Carl
`
`56(10,2011).579—588;
`J Psychiatry
`H.
`SADOWSKY and James
`E GaIVIn
`Gu
`
`idelines for
`
`the management
`
`of cognitive
`
`and behavioral problems
`
`in dementia
`
`J
`
`Am Board Fam Med 25(2012)
`[0031]
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
